PREGABALIN | A210432 | RISING PHARMA HOLDINGS INC
Highest NADAC/Unit
$0.0658
per ea
Lowest NADAC/Unit
$0.0428
per ea
Brand NDCs
0
Generic NDCs
26
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 64980041709PREGABALIN 300 MG CAPSULE | $0.0658 | EA | Generic | — | 2026-06-17 |
| 00904700504PREGABALIN 300 MG CAPSULE | $0.0658 | EA | Generic | — | 2026-06-17 |
| 00904700304PREGABALIN 200 MG CAPSULE | $0.0573 | EA | Generic | — | 2026-06-17 |
| 64980041509PREGABALIN 200 MG CAPSULE | $0.0573 | EA | Generic | — | 2026-06-17 |
| 64980041609PREGABALIN 225 MG CAPSULE | $0.0555 | EA | Generic | — | 2026-06-17 |
| 00904700404PREGABALIN 225 MG CAPSULE | $0.0555 | EA | Generic | — | 2026-06-17 |
Showing 6 of 26 NDCs.
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.